NASDAQ:ABOS

Acumen Pharmaceuticals, Inc.

Stock

USD

Last Close

1.90

06/11 21:09

Market Cap

137.58M

Beta: -

Volume Today

129.63K

Avg: 100.61K

PE Ratio

−3.53

PFCF: −3.92

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-7.91M -	-7.33M 7.36%	-100.61M 1,273.46%	-42.86M 57.40%	-52.37M 22.20%
depreciation and amortization			4K -	169K 4,125%	-3.06M 1,910.65%
deferred income tax			155K -
stock based compensation	174K -	154K 11.49%	922K 498.70%	3.06M 232.00%	6.14M 100.75%
change in working capital	768K -	307K 60.03%	298K 2.93%	3.99M 1,237.58%	-261K 106.55%
accounts receivables	200K -	-79K 139.50%
inventory	-200K -	79K 139.50%
accounts payables	110K -	308K 180%	557K 80.84%	552K 0.90%	-261K 147.28%
other working capital	658K -	-1K 100.15%	-259K 25,800%	3.43M 1,425.87%	261K 92.40%
other non cash items	147K -	-586K 498.64%	81.27M 13,967.92%	487K 99.40%	6.22M 1,177.62%
net cash provided by operating activities	-6.82M -	-7.45M 9.27%	-17.96M 141.09%	-35.15M 95.72%	-43.06M 22.50%
investments in property plant and equipment			-40K -	-161K 302.50%	-21K 86.96%
acquisitions net				-39.35K -
purchases of investments			-104.08M -	-41.51M 60.11%	-250.63M 503.73%
sales maturities of investments				80.86M -	78.98M 2.32%
other investing activites				39.35K -	3K 92.38%
net cash used for investing activites			-104.12M -	39.19M 137.63%	-171.67M 538.10%
debt repayment
common stock issued	6.24M -	44.67M 616.06%	168.56M 277.29%	3.79M 97.75%	121.90M 3,114.77%
common stock repurchased
dividends paid
other financing activites	6.24K -	44.67K 616.06%	31.91M 71,326.97%	115K 99.64%	29.85M 25,855.65%
net cash used provided by financing activities	6.24M -	44.67M 616.06%	200.47M 348.72%	3.91M 98.05%	151.75M 3,784.13%
effect of forex changes on cash
net change in cash	-579K -	37.23M 6,529.19%	78.39M 110.57%	7.94M 89.87%	-62.98M 893.32%
cash at beginning of period	7.13M -	6.55M 8.12%	43.78M 568.15%	122.16M 179.06%	130.10M 6.50%
cash at end of period	6.55M -	43.78M 568.15%	122.16M 179.06%	130.10M 6.50%	67.12M 48.41%
operating cash flow	-6.82M -	-7.45M 9.27%	-17.96M 141.09%	-35.15M 95.72%	-43.06M 22.50%
capital expenditure			-40K -	-161K 302.50%	-21K 86.96%
free cash flow	-6.82M -	-7.45M 9.27%	-18.00M 141.62%	-35.31M 96.18%	-43.09M 22.01%

All numbers in USD (except ratios and percentages)